Recursion Pharmaceuticals, Inc. (RXRX)
Market Closed
8 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 82
+0.11
+2.34%
$
1.86B Market Cap
- P/E Ratio
0% Div Yield
34,795,684 Volume
-1.72 Eps
$ 4.71
Previous Close Day Range
4.68 5.09
Year Range
3.79 12.36
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| RXRX Recursion Pharmaceuticals, Inc. 4 Mar 2026 (In 2 months) | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 27 Feb 2026 (In 2 months) | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 5 Nov 2025 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 4 Nov 2025 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 12 Aug 2025 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 7 May 2025 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 25 Feb 2025 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 7 Nov 2024 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 6 Aug 2024 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 6 May 2024 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 26 Feb 2024 | | - | - |
| RXRX Recursion Pharmaceuticals, Inc. 6 Nov 2023 | | - | - |
RXRX Earnings Reports FAQ
What is the earnings per share (EPS) for RXRX?
The current EPS is -1.72.
What is the company's earnings growth rate?
Recursion Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-27, based on the RXRX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Recursion Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RXRX at this time, as Recursion Pharmaceuticals, Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
